Skip to content

BIOGEN INC.

BIIB

CIK 0000875045

← back to feed
Revenue (TTM)
$10.09B
+2.2% YoY Q1 Apr 2026
Net Income (TTM)
$1.66B
−20.8% YoY Q1 Apr 2026
EPS Diluted (TTM)
$11.29
−21.4% YoY Q1 Apr 2026
Gross Margin
23.4%
Q1 Apr 2026
Operating Margin
28.4%
Q1 Apr 2026
Net Margin
16.5%
Q1 Apr 2026
Free Cash Flow (TTM)
$1.71B
Q1 Apr 2026
Cash
$2.91B
Q1 Apr 2026
Total Debt
$6.29B
Q1 Apr 2026
Shares Outstanding
147.64M sh
Q1 Apr 2026

Revenue & Net Income

EPS (Diluted)

Margins

Cash Flow

Revenue Growth (YoY)

Balance Sheet

Cash vs Debt

Recent filings